background
middl
east
respiratori
syndrom
coronaviru
merscov
discov
septemb
kingdom
saudi
arabia
ksa
first
us
case
merscov
confirm
may
method
summar
clinic
symptom
sign
laboratori
radiolog
find
merscovspecif
test
result
patient
physician
work
hospit
ksa
merscov
patient
treat
ill
onset
includ
malais
myalgia
lowgrad
fever
flew
unit
state
day
ill
doi
first
respiratori
symptom
dri
cough
develop
doi
doi
present
indiana
hospit
dyspneic
hypox
right
lower
lobe
infiltr
chest
radiographi
doi
serum
test
posit
realtim
revers
transcript
polymeras
chain
reaction
rrtpcr
merscov
show
high
merscov
antibodi
titer
wherea
nasopharyng
swab
rrtpcr
neg
expector
sputum
rrtpcr
posit
follow
day
high
viral
load
copiesml
treat
antibiot
intraven
immunoglobulin
oxygen
nasal
cannula
discharg
doi
genom
sequenc
similar
known
merscov
sequenc
cluster
ksa
june
juli
conclus
patient
prolong
nonspecif
prodrom
ill
develop
respiratori
symptom
sera
sputum
rrtpcr
posit
nasopharyng
specimen
neg
us
clinician
must
vigil
merscov
patient
febril
andor
respiratori
ill
recent
travel
arabian
peninsula
especi
among
healthcar
worker
middl
east
respiratori
syndrom
coronaviru
merscov
first
report
septemb
saudi
arabian
patient
pneumonia
may
merscov
confirm
world
health
organ
patient
case
relat
resid
recent
travel
contact
recent
travel
arabian
peninsula
initi
report
clinic
cours
among
merscov
case
patient
saudi
arabia
reveal
high
case
fatal
proport
subsequ
increas
test
symptomat
asymptomat
person
part
contact
investig
reveal
approxim
onefifth
onequart
case
mildli
symptomat
asymptomat
april
travelassoci
case
detect
countri
outsid
arabian
peninsula
report
clinic
cours
laboratori
find
first
case
merscov
unit
state
patient
clinic
histori
possibl
exposur
merscov
elicit
direct
interview
patient
famili
member
physic
laboratori
radiolog
find
extract
medic
record
specimen
drawn
hospit
sent
ice
indiana
depart
health
idh
laboratori
center
diseas
control
prevent
cdc
initi
test
realtim
revers
transcript
polymeras
chain
reaction
rrtpcr
perform
idh
laboratori
confirmatori
sequenc
perform
cdc
cdc
rrtpcr
screen
assay
consist
signatur
target
region
upstream
merscov
envelop
protein
gene
upe
nucleocapsid
gene
posit
test
result
either
assay
confirm
third
rrtpcr
assay
also
target
nucleocapsid
gene
serolog
done
use
recombin
merscov
nucleocapsid
proteinbas
enzymelink
immunosorb
assay
elisa
develop
cdc
elisa
develop
use
modifi
version
n
elisa
describ
brief
sera
consid
posit
optic
densiti
od
valu
cutoff
valu
mean
absorb
nm
sera
us
blood
donor
plu
standard
deviat
overal
specif
assay
determin
screen
serum
sampl
donor
unit
state
middl
east
person
nonmer
respiratori
infect
eg
human
coronaviru
hcov
sever
acut
respiratori
syndrom
sar
coronaviru
rhinoviru
human
metapneumoviru
assay
specif
serum
human
sera
avail
evalu
howev
mous
hyperimmun
serum
crossreact
merscov
n
protein
screen
dilut
sera
od
valu
near
cutoff
titrat
serial
dilut
assay
sensit
determin
screen
limit
number
serum
sampl
individu
confirm
merscov
infect
sera
provid
public
health
england
robert
koch
institut
jordan
ministri
health
confirmatori
test
merscovspecif
antibodi
done
posit
elisa
merscov
immunofluoresc
microneutr
assay
confirmatori
assay
evalu
use
similar
panel
sera
describ
similar
specif
serolog
test
done
cdc
full
genom
sequenc
determin
rna
obtain
directli
sputum
collect
day
ill
doi
gener
tile
amplicon
across
viru
genom
follow
sanger
sequenc
sequenc
deposit
genbank
databas
access
number
patient
male
physician
live
kingdom
saudi
arabia
ksa
report
onset
fatigu
mild
myalgia
april
doi
curtail
daili
exercis
program
report
lowgrad
fever
respiratori
symptom
doi
patient
began
acetaminophen
naproxen
myalgia
also
began
cours
ciprofloxacin
due
histori
prostat
improv
went
emerg
depart
ksa
doi
normal
complet
blood
count
cbc
normal
chest
radiograph
report
test
merscov
patient
flew
ksa
london
april
doi
london
chicago
arriv
day
took
bu
famili
home
indiana
upon
arriv
patient
sister
notic
appear
fatigu
attribut
jet
lag
doi
patient
record
oral
temperatur
famili
suggest
start
oseltamivir
possibl
influenza
nonproduct
cough
develop
doi
doi
develop
visibl
dyspnea
tachypnea
use
albuterol
meterdos
inhal
day
without
improv
prompt
sister
drive
emerg
depart
local
hospit
patient
hypertens
coronari
arteri
diseas
stent
place
year
ago
also
benign
prostat
hypertrophi
prostat
year
ago
medic
includ
valsartan
atenolol
atorvastatin
clopidogrel
smoke
drink
alcohol
patient
work
fulltim
larg
hospit
riyadh
attend
patient
outpati
inpati
set
includ
emerg
depart
recal
directli
treat
patient
known
merscov
infect
april
awar
merscovposit
patient
hospit
month
april
enter
room
sever
intub
patient
part
work
extens
direct
contact
patient
recal
examin
patient
undergo
nebul
treatment
wear
surgic
mask
deni
present
intub
respiratori
suction
last
day
work
april
day
travel
saudi
arabia
live
famili
member
household
employe
none
ill
week
symptom
onset
patient
deni
contact
known
merscov
patient
outsid
work
also
deni
physic
contact
consumpt
camel
camel
product
present
emerg
depart
indiana
hospit
april
doi
patient
oral
temperatur
blood
pressur
mm
hg
heart
rate
beatsminut
respiratori
rate
breathsminut
oxygen
satur
sat
room
air
pulmonari
exam
reveal
right
lower
quadrant
rhonchi
decreas
breath
sound
cardiovascular
abdomin
skin
neurolog
musculoskelet
exam
unremark
admiss
laboratori
data
remark
lymphopenia
total
lymphocyt
count
l
mildli
elev
liver
function
test
slight
hyponatremia
mildli
elev
inflammatori
marker
tabl
laboratori
result
within
normal
limit
chest
radiographi
admiss
show
right
lower
lobe
infiltr
figur
patient
initi
place
lminut
oxygen
nasal
cannula
given
antibiot
vancomycin
piperacillin
tazobactam
hospitalacquir
pneumonia
admit
medic
floor
patient
maximum
temperatur
doi
requir
increas
l
minut
comput
tomographi
chest
doi
show
bilater
infiltr
predominantli
lower
lobe
figur
doi
levofloxacin
ad
coverag
atyp
pneumonia
pathogen
given
continu
fever
replac
ceftriaxon
doi
legionella
mycoplasma
pneumonia
test
return
neg
doi
patient
afebril
decreas
requir
lminut
maintain
sat
also
receiv
dose
mgkg
intraven
immunoglobulin
ivig
doi
doi
patient
thought
volum
overload
chest
radiograph
show
worsen
bilater
infiltr
increas
requir
lminut
day
furosemid
start
brisk
diuresi
via
foley
cathet
oxygen
wean
rapidli
lminut
oral
antibiot
linezolid
levofloxacin
start
doi
patient
longer
requir
oxygen
sat
room
air
improv
chest
radiograph
doi
total
lymphocyt
count
remain
low
throughout
hospit
stay
nadir
l
discharg
valu
l
element
cbc
electrolyt
includ
renal
function
remain
within
normal
limit
subsequ
test
sever
microbiolog
test
apart
merscov
test
includ
neg
blood
cultur
doi
neg
sputum
cultur
doi
neg
multiplex
pcr
common
respiratori
pathogen
biofir
diagnost
utah
april
neg
urin
antigen
test
pneumococcu
pneumonia
legionella
pneumophila
doi
patient
discharg
home
stabl
condit
doi
patient
initi
posit
rrtpcr
merscov
serum
first
collect
april
doi
although
nasopharyng
np
sampl
neg
date
serum
antibodi
titer
patient
addit
posit
sampl
sputum
doi
oropharyng
swab
doi
plasma
doi
tabl
viral
load
sputum
doi
copiesml
doi
viral
load
decreas
copiesml
sputum
sampl
antibodi
titer
antibodi
titer
remain
high
last
day
collect
doi
stool
urin
test
neg
merscov
date
attempt
cultur
viru
sputum
doi
sampl
unsuccess
genom
sequenc
nt
similar
known
merscov
sequenc
cluster
close
humanderiv
merscov
strain
obtain
riyadh
hafralbatin
summer
figur
supplementari
figur
patient
spent
hour
emerg
depart
entir
time
privat
triag
room
admit
gener
medic
floor
privat
room
without
airborn
contact
precaut
approxim
hour
place
airborn
precaut
doi
hospit
day
remain
privat
room
neg
pressur
rel
hallway
doi
contact
precaut
ad
patient
move
negativepressur
room
precaut
maintain
throughout
remaind
hospit
stay
report
first
case
merscov
unit
state
sever
aspect
patient
clinic
present
cours
provid
insight
merscov
diseas
first
rel
prolong
period
system
symptom
malais
myalgia
lowgrad
fever
last
day
develop
first
respiratori
symptom
although
seri
critic
ill
merscov
patient
median
time
ill
onset
admiss
day
protract
sequenc
align
gener
use
nearli
complet
genom
sequenc
publish
genbank
ii
health
protect
agenc
nonrespiratori
ill
week
describ
patient
eventu
signific
bilater
lung
infiltr
patient
although
patient
indiana
eventu
develop
dri
cough
occur
approxim
half
merscov
patient
cough
never
promin
despit
extens
lung
parenchym
involv
second
patient
clinic
present
radiolog
laboratori
find
distinguish
featur
merscov
infect
could
easili
diagnos
common
viral
bacteri
pneumonia
etiolog
wherea
patient
preval
symptom
observ
largest
seri
merscov
patient
saudi
arabia
fever
cough
short
breath
lack
upper
respiratori
tract
eg
sore
throat
rhinorrhea
gastrointestin
tract
symptom
eg
diarrhea
vomit
seen
approxim
onequart
merscov
patient
patient
laboratori
data
unremark
except
mild
elev
liver
enzym
seen
patient
lymphopenia
seen
patient
mild
elev
inflammatori
marker
key
featur
diagnosi
merscov
patient
histori
practic
recent
travel
ksa
time
case
approxim
merscov
case
worldwid
occur
ksa
infect
among
healthcar
worker
well
document
number
confirm
merscov
case
identifi
ksa
increas
substanti
march
earli
may
case
confirm
march
may
merscov
case
preval
arabian
peninsula
us
clinician
need
ever
vigil
merscov
among
patient
compat
clinic
present
eg
fever
sever
respiratori
ill
travel
histori
ie
ill
onset
within
day
travel
arabian
peninsula
nearbi
countri
close
contact
confirm
probabl
case
although
patient
recal
close
contact
work
healthcar
set
ksa
suggest
potenti
unrecogn
close
contact
ten
day
patient
confirm
diagnosi
second
import
case
merscov
detect
florida
anoth
healthcar
worker
also
work
ksa
us
case
occur
date
indiana
patient
suspect
merscov
infect
diagnosi
made
within
hour
viru
first
detect
patient
serum
np
swab
neg
np
swab
eas
collect
common
sampl
use
make
diagnosi
merscov
nonetheless
evid
merscov
case
even
high
load
viru
detect
lower
respiratori
tract
specimen
upper
respiratori
tract
specimen
weakli
posit
neg
patient
initi
np
sampl
neg
time
sputum
posit
rrtpcr
merscov
concentr
high
tracheobronchi
secret
patient
critic
ill
moreov
sputum
remain
posit
day
longer
pharyng
sampl
serum
also
posit
rrtpcr
occas
period
nasopharyng
sampl
neg
suggest
prolong
viremia
blood
serum
sampl
found
rrtpcr
posit
patient
merscov
might
sensit
diagnost
specimen
merscov
patient
sar
patient
contrast
sar
merscov
rare
detect
stool
detect
present
rel
low
concentr
diagnost
test
person
investig
merscov
cdc
state
lower
respiratori
specimen
includ
induc
expector
sputa
prefer
howev
collect
nporopharyng
op
specimen
well
stool
serum
also
recommend
soon
possibl
symptom
onset
symptom
onset
day
ago
singl
serum
specimen
serolog
test
addit
lower
respiratori
specimen
npop
specimen
recommend
although
kinet
antibodi
respons
merscov
infect
need
clarif
despit
bilater
pulmonari
infiltr
patient
requir
supplement
oxygen
nasal
cannula
abl
wean
room
air
day
admiss
evid
yet
effect
treatment
merscov
infect
case
seri
saudi
merscov
patient
bacteri
coinfect
diagnos
although
bacteri
pneumonia
superinfect
commonli
seen
follow
influenza
viru
infect
demonstr
novel
coronavirus
permiss
recommend
antibiot
base
clinic
judgment
patient
novel
coronaviru
infect
ivig
evalu
merscov
patient
unlik
effect
patient
recoveri
given
nonsever
clinic
statu
expect
absenc
merscov
antibodi
pool
sera
unit
state
immunomodulatori
effect
ivig
patient
unknown
although
ivig
administ
patient
sarscov
infect
effect
ivig
treatment
sar
patient
unknown
due
confound
variabl
sever
ill
treatment
initi
uncontrol
studi
design
due
potenti
risk
unknown
benefit
ivig
recommend
treat
merscov
patient
wherea
interferon
ribavirin
combin
therapi
shown
therapeut
potenti
cell
cultur
anim
experi
treatment
shown
effect
merscov
patient
howev
agent
implement
late
cours
ill
steroid
also
recommend
treatment
merscov
close
genet
relat
strain
patient
riyadh
juli
indiana
patient
live
work
hospit
interest
next
close
relat
viru
june
index
case
commun
cluster
hafr
albatin
town
northeast
ksa
near
kuwaiti
border
approxim
km
riyadh
supplementari
figur
sequenc
present
genbank
databas
particularli
riyadh
ongo
threat
spread
merscov
unit
state
requir
vigil
astut
clinician
public
health
depart
detect
merscovinfect
patient
respond
rapidli
prevent
spread
healthcar
facil
commun
peopl
travel
provid
healthcar
servic
arabian
peninsula
familiar
recommend
infect
control
confirm
suspect
mer
case
supplementari
materi
avail
clinic
infecti
diseas
onlin
http
cidoxfordjournalsorg
supplementari
materi
consist
data
provid
author
publish
benefit
reader
post
materi
copyedit
content
supplementari
data
sole
respons
author
question
messag
regard
error
address
author
